Skip to main content
Premium Trial:

Request an Annual Quote

Enzo Biochem, Agilent Settle Patent Infringement Lawsuit

NEW YORK (GenomeWeb) – Agilent Technologies will pay Enzo Biochem $9 million to settle a patent infringement lawsuit between the companies, Enzo said today.

The suit alleged that Agilent had infringed on Enzo's U.S. Patent No. 7,064,197  for non-porous solid supports for fixed or immobilized nucleic acids. The legal action is more than a decade old — Enzo originally sued several companies, including PerkinElmer, Sigma-Aldrich, GE Healthcare, Affymetrix, Orchid Biosciences, Molecular Probes, and Roche, claiming the companies were infringing on eight different patents by selling certain reagent kits.

PerkinElmer settled with Enzo in June 2014 for $7 million, Siemens settled in July 2015 for an upfront payment of $9.5 million, Luminex settled in July 2015 for $7.1 million, and Affymetrix settled in October for $10 million.

In all, Enzo still has eight infringement cases pending before the court, the company said in a statement.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.